Scandinavian Biopharma Holding AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Scandinavian Biopharma Holding AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11298
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Scandinavian Biopharma Holding AB (Scandinavian) is a biotechnology company that distributes vaccines and immunoglobulin. The company offers diagnostics, vaccines, dental and immunoglobulin products. Its products are used in the therapeutic areas of diphtheria and tetanus, tuberculosis, polio, and pertussis. Scandinavian offers contract research and process development services including development strategies, genetic constructions, project management, construction of master and working cell banks; development of fermentation process and down-stream purification, analytical methods development and validation; stability testing, potency assay development, clinical trial services, and others. The company works in partnership with manufacturers within the vaccines, dental and immunoglobulin area. Scandinavian is headquartered in Stockholm, Sweden.

Scandinavian Biopharma Holding AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Scandinavian Biopharma Enters into Agreement with Flynn Pharma 10
Scandinavian Biopharma Enters into Distribution Agreement with Neovii Pharma 11
Scandinavian Biopharma, PATH and University of Gothenburg Amend Agreement to Develop ETEC 12
Scandinavian Biopharma Holding AB – Key Competitors 13
Scandinavian Biopharma Holding AB – Key Employees 14
Scandinavian Biopharma Holding AB – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
Jun 08, 2017: Scandinavian Biopharma continues to grow – 2016 was another successful year 16
Government and Public Interest 17
Apr 25, 2018: Scandinavian Biopharma gets support by the County Administrative Board in Stockholm 17
Other Significant Developments 18
May 22, 2018: Scandinavian Biopharma is once again looking back on a highly successful business year 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Key Facts 2
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scandinavian Biopharma Holding AB, Deals By Therapy Area, 2012 to YTD 2018 8
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Scandinavian Biopharma Enters into Agreement with Flynn Pharma 10
Scandinavian Biopharma Enters into Distribution Agreement with Neovii Pharma 11
Scandinavian Biopharma, PATH and University of Gothenburg Amend Agreement to Develop ETEC 12
Scandinavian Biopharma Holding AB, Key Competitors 13
Scandinavian Biopharma Holding AB, Key Employees 14
Scandinavian Biopharma Holding AB, Subsidiaries 15

List of Figures
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Scandinavian Biopharma Holding AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • XALT Energy LLC:企業の戦略的SWOT分析
    XALT Energy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • ConCardis GmbH:企業の戦略・SWOT・財務情報
    ConCardis GmbH - Strategy, SWOT and Corporate Finance Report Summary ConCardis GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Charter Communications Inc (CHTR):企業の財務・戦略的SWOT分析
    Charter Communications Inc (CHTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Ferrovial, S.A.:企業の戦略・SWOT・財務分析
    Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report Summary Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Denbury Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Denbury Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Denbury Resources Inc (Denbury) is an independent oil and natural gas company. It carries out exploration, development and production of oil and natural gas from its assets in the Gulf Coast an …
  • MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析
    Summary MiMedx Group Inc (MiMedx) develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary purion process that separates placental …
  • TGS-NOPEC Geophysical Company ASA (TGS):石油・ガス:M&Aディール及び事業提携情報
    Summary TGS-NOPEC Geophysical Company ASA (TGS) is a provider of exploration services. It offers multi-client geosciences data to oil and gas exploration and production companies. The company offers a range of global geophysical and geological data libraries including multi-client seismic data, magn …
  • Apetit Oyj:企業の戦略・SWOT・財務情報
    Apetit Oyj - Strategy, SWOT and Corporate Finance Report Summary Apetit Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • PPL Corporation (PPL):電力:M&Aディール及び事業提携情報
    Summary PPL Corporation (PPL) is an energy holding company. Through its subsidiaries, LG&E, Kentucky Utilities, and KU Energy, it generates, transmits, distributes, and sells electricity; and distributes and sells natural gas. The company produces electricity from coal, natural gas, oil, hydro, and …
  • The Hartford Financial Services Group, Inc.:企業のM&A・事業提携・投資動向
    The Hartford Financial Services Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Hartford Financial Services Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Marston’s PLC:企業の戦略・SWOT・財務情報
    Marston's PLC - Strategy, SWOT and Corporate Finance Report Summary Marston's PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Bankers Petroleum Ltd.:企業の戦略的SWOT分析
    Bankers Petroleum Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Prescient Therapeutics Ltd (PTX):企業の財務・戦略的SWOT分析
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd, is a biotechnology company which develops novel medicines for cancer treatment. The company is investigating OmniCAR, an immune receptor platform that controls T-cell activity and multi-antigen targeting with a …
  • New York & Company, Inc.:企業の戦略・SWOT・財務情報
    New York & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary New York & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • OraSolv AB (OS):企業の財務・戦略的SWOT分析
    OraSolv AB (OS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Eisai Inc:企業の戦略的SWOT分析
    Eisai Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Cordis Corp:医療機器:M&Aディール及び事業提携情報
    Summary Cordis Corporation (Cordis), a subsidiary of a Cardinal Health Inc., develops and manufactures interventional vascular products in the area of cardiology as well as for use in endovascular surgery. The company’s cardiology portfolio comprises sheaths, diagnostic guidewires, diagnostic cathet …
  • Woolworths Ltd (WOW):企業の財務・戦略的SWOT分析
    Woolworths Ltd (WOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Aker Solutions ASA (AKSO):企業の財務・戦略的SWOT分析
    Aker Solutions ASA (AKSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • SmarTone Telecommunications Holdings Ltd (315):企業の財務・戦略的SWOT分析
    SmarTone Telecommunications Holdings Ltd (315) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆